Insider Buying: Pressure BioSciences CEO Purchases 20,500 Shares of Stock (PBIO)
Pressure BioSciences (NASDAQ:PBIO) CEO Richard Schumacher bought 20,500 shares of the stock on the open market in a transaction dated Thursday, September 12th. The shares were purchased at an average cost of $0.30 per share, with a total value of $6,150.00. Following the acquisition, the chief executive officer now directly owns 653,804 shares of the company’s stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Pressure BioSciences (NASDAQ:PBIO) remained flat at $0.30 during trading on Thursday. 17,500 shares of the company’s stock traded hands. Pressure BioSciences has a 1-year low of $0.15 and a 1-year high of $0.51. The stock’s 50-day moving average is $0.26 and its 200-day moving average is $0.31. The company’s market cap is $3.4 million.
Pressure BioSciences (NASDAQ:PBIO) last released its earnings data on Thursday, August 15th. The company reported ($0.10) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.06) by $0.04. Analysts expect that Pressure BioSciences will post $-0.29 earnings per share for the current fiscal year.
Pressure BioSciences, Inc is focused on solving the challenging problems inherent in biological sample preparation, a crucial laboratory step performed by scientists worldwide working in biological life sciences research.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.